2011 - Page 147 of 319 - Shapiro, Washburn & Sharp

FDA Issues Public Notice Regarding Transvaginal Mesh Implant Surgery

The Food and Drug Administration has issued a public notice encouraging doctors and patients to explore alternatives to implantable surgical mesh when repairing pelvic organ prolapse and stress urinary incontinence. The conditions frequently occur after childbirth and pregnancy, and in 2010, more than 75,000 women had transvaginal surgery implant surgical mesh to repair POP. The warning comes…

read more